2XMY | Transferase | date | Jul 29, 2010 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Discovery And Characterisation Of 2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional Cdk Inhibitors As Anticancer Age | ||||||||||||||
authors | S.Wang, G.Griffiths, C.A.Midgley, A.L.Barnett, M.Cooper, J.Grabar L.Ingram, W.Jackson, G.Kontopidis, S.J.Mcclue, C.Mcinnes, J.Mcla C.Meades, M.Mezna, I.Stuart, M.P.Thomas, D.I.Zheleva, D.P.Lane, R.C.Jackson, D.M.Glover, D.G.Blake, P.M.Fischer | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Cell Division Protein Kinase 2 Chain: A Synonym: P33 Protein Kinase Ec: 2.7.1.37, 2.7.11.22 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Expression_system: Spodoptera Frugiperda Expression_system_common: Fall Armyworm Expression_system_taxid: 7108 Expression_system_cell_line: Sf9 Expression_system_vector_type: Baculovirus | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.90 Å | ||||||||||||
ligand | CDK BindingDB | enzyme | Transferase E.C.2.7.1.37 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Discovery and characterization of 2-anilino-4- (thiazol-5-yl)pyrimidine transcriptional CDK inhibitors as anticancer agents., Wang S, Griffiths G, Midgley CA, Barnett AL, Cooper M, Grabarek J, Ingram L, Jackson W, Kontopidis G, McClue SJ, McInnes C, McLachlan J, Meades C, Mezna M, Stuart I, Thomas MP, Zheleva DI, Lane DP, Jackson RC, Glover DM, Blake DG, Fischer PM, Chem Biol. 2010 Oct 29;17(10):1111-21. PMID:21035734 |
Data retrieval |
View 2XMY in 3D |
Visual 3D analysis of 2XMY |
Structure-derived information |
Sequence-derived information |
Other resources with information on 2XMY |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |